IRVINE, Calif., June 12, 2023 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, today announced that it will host a virtual event to provide an overview…Read More
Tarsus to Host Virtual Investor Webcast Highlighting the Commercialization Strategy Plans and Progress for TP03 Its Potential Treatment for Demodex Blepharitis
